426 related articles for article (PubMed ID: 17948029)
1. The 'kiss of death' by dendritic cells to cancer cells.
Chan CW; Housseau F
Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
[TBL] [Abstract][Full Text] [Related]
3. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
4. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells and dendritic cells: rendezvous in abused tissues.
Moretta A
Nat Rev Immunol; 2002 Dec; 2(12):957-64. PubMed ID: 12461568
[TBL] [Abstract][Full Text] [Related]
6. Early liaisons between cells of the innate immune system in inflamed peripheral tissues.
Moretta A; Marcenaro E; Sivori S; Della Chiesa M; Vitale M; Moretta L
Trends Immunol; 2005 Dec; 26(12):668-75. PubMed ID: 16198147
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells in cancer immunotherapy.
Gunzer M; Grabbe S
Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
[TBL] [Abstract][Full Text] [Related]
8. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.
Harizi H; Gualde N
Tissue Antigens; 2005 Jun; 65(6):507-14. PubMed ID: 15896197
[TBL] [Abstract][Full Text] [Related]
9. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
11. A central role for tissue-resident dendritic cells in innate responses.
Foti M; Granucci F; Ricciardi-Castagnoli P
Trends Immunol; 2004 Dec; 25(12):650-4. PubMed ID: 15530834
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy.
Wu Y; Wang L; Zhang Y
Cell Mol Immunol; 2004 Oct; 1(5):351-6. PubMed ID: 16285894
[TBL] [Abstract][Full Text] [Related]
13. Modulating vaccine responses with dendritic cells and Toll-like receptors.
Pulendran B
Immunol Rev; 2004 Jun; 199():227-50. PubMed ID: 15233738
[TBL] [Abstract][Full Text] [Related]
14. Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts.
Mohty M; Olive D; Gaugler B
Leukemia; 2002 Nov; 16(11):2197-204. PubMed ID: 12399962
[TBL] [Abstract][Full Text] [Related]
15. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer.
Seya T; Akazawa T; Uehori J; Matsumoto M; Azuma I; Toyoshima K
Anticancer Res; 2003; 23(6a):4369-76. PubMed ID: 14666723
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity: cells, receptors, and signaling pathways.
Błach-Olszewska Z
Arch Immunol Ther Exp (Warsz); 2005; 53(3):245-53. PubMed ID: 15995585
[TBL] [Abstract][Full Text] [Related]
17. The dialogue between human natural killer cells and dendritic cells.
Moretta A
Curr Opin Immunol; 2005 Jun; 17(3):306-11. PubMed ID: 15886122
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between dendritic cells and natural killer cells in viral infection.
Andrews DM; Andoniou CE; Scalzo AA; van Dommelen SL; Wallace ME; Smyth MJ; Degli-Esposti MA
Mol Immunol; 2005 Feb; 42(4):547-55. PubMed ID: 15607812
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific killer cells in paraneoplastic cerebellar degeneration.
Albert ML; Darnell JC; Bender A; Francisco LM; Bhardwaj N; Darnell RB
Nat Med; 1998 Nov; 4(11):1321-4. PubMed ID: 9809559
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells (II): Role and therapeutic implications in cancer.
Satthaporn S; Eremin O
J R Coll Surg Edinb; 2001 Jun; 46(3):159-67. PubMed ID: 11478013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
